Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer

BACKGROUND: Patients with luminal HER2-negative tumours have a favourable prognosis. However, there is a subpopulation in which poorer outcomes are obtained with endocrine therapy alone. This subpopulation is considered to benefit from chemotherapy. However, the significance of chemotherapy for thos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Horimoto, Yoshiya, Arakawa, Atsushi, Tanabe, Masahiko, Sonoue, Hiroshi, Igari, Fumie, Senuma, Koji, Tokuda, Emi, Shimizu, Hideo, Kosaka, Taijiro, Saito, Mitsue
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124146/
https://ncbi.nlm.nih.gov/pubmed/25073969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-550
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars